Company intelligence / Profile preview

CRS Clinical Research Services

Andernach, Rheinland-Pfalz, Germanycrs-earlyphase.com ↗

Ownership: Private
Employees: ~264
Development stage: Commercial

Overview

CRS Clinical Research Services is one of Europe’s leading full-service early phase contract research organizations. With over four decades of experience and three state-of-the-art units in Germany, it specializes in First-in-Human to Proof-of-concept studies across metabolic/cardiovascular disorders, diabetes, dermatology, hepatic/renal impairment and more. In January 2025, it was acquired by hVIVO.

Therapeutic areas: Metabolic DisordersPulmonologyOtherDermatologyGastroenterologyNephrology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on CRS Clinical Research Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRS Clinical Research Services.

Explore the full profile